A hospitalized woman who sued Johnson and Johnson, alleging the talcum in the company’s baby powder caused her ovarian cancer has been awarded $417 million by a jury in Los Angeles.

The successful lawsuit is the latest multi-million dollar hit against the company and its talc-containing products – it is also the largest sum yet awarded.

“We are grateful for the jury’s verdict on this matter and that Eva Echeverria was able to have her day in court,” said Mark Robinson, the woman’s attorney. “These cases are about fighting for justice for women all over California who are suffering from ovarian cancer because of Johnson and Johnson’s covering up the truth for so many years.”

Echeverria used the baby powder in a daily regimen from the 1950s until last year. She was diagnosed with ovarian cancer in 2007. She alleges that the company has not properly placed warnings on the product, and she would have stopped using it if there had been indications of potential health effects.

The jury agreed, 9-3, with her claims. The award includes $70 million in compensatory damages and $347 million in punitive damages. Echeverria was not in court to see the proceedings, since her condition is terminal and she is hospitalized, according to her attorneys.

The New Jersey-based Johnson and Johnson has previously lost cases in Missouri totaling some $300 million. But it also still faces approximately 4,800 claims nationally – with another 300 consolidated cases in Los Angeles County alone, according to Courtroom View Network.

The company said they would continue to fight the claims.

“We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder,” said Carol Goodrich, a J&J spokeswoman, in a statement Monday.

The company also pointed to an April finding by the National Cancer Institute’s Physician Data Query Editorial Board: “The weight of evidence does not support an association between perineal talc exposure and an increased risk of ovarian cancer.”

Nevertheless, juries continue to side with the sufferers of ovarian cancers who blame the company’s talcum-containing products.

One of the four successful suits in Missouri was brought by Jacqueline Fox, of Birmingham, Ala., who claimed that she used the baby powder and Shower to Shower for decades, before being diagnosed with ovarian cancer in 2014. She died in October 2015 – but her surviving family was awarded $72 million in damages in February 2016. Another of the cases yielded a jury award of $110 million.

The debate over talcum powder, which is a naturally-occurring material made of magnesium silicon and other elements – but which bears some similarity to asbestos – continues. A potential problem was identified nearly half a century ago: as early as 1971, scientists had identified that ovarian tumors contained high concentrations of talcum. The World Health Organization has also identified the material used mostly in cosmetic products as “possibly carcinogenic to humans,” though it has made no definitive determination.

However, the American Cancer Society has not reached any conclusion on whether the substance causes tumors, since different lab studies on lung and ovarian cancer have reached very different results.

The Associated Press contributed to this report.